Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Salix Pharmaceuticals Company Profile (NASDAQ:SLXP)

Consensus Ratings for Salix Pharmaceuticals (NASDAQ:SLXP) (?)
Ratings Breakdown: 14 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Hold (Score: 2.30)
Consensus Price Target: $138.40 (12.09% downside)

Current Analysts' Coverage Summary for Salix Pharmaceuticals (NASDAQ:SLXP)
Show:
DateFirmActionRatingPrice TargetDetailsShare
2/24/2015Cantor FitzgeraldDowngradeBuy -> Hold$151.00 -> $158.00ViewTweet This Rating  Share This Rating on StockTwits
2/23/2015MizuhoBoost Price TargetNeutral$149.00 -> $158.00ViewTweet This Rating  Share This Rating on StockTwits
2/23/2015Leerink SwannDowngradeOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
2/23/2015Piper JaffrayDowngradeOverweight -> Neutral$160.00 -> $158.00ViewTweet This Rating  Share This Rating on StockTwits
2/12/2015Sterne AgeeDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
2/2/2015ZacksReiterated RatingNeutral -> Neutral$141.00ViewTweet This Rating  Share This Rating on StockTwits
1/29/2015Jefferies GroupBoost Price TargetBuy$138.00 -> $149.00ViewTweet This Rating  Share This Rating on StockTwits
12/18/2014Deutsche BankReiterated RatingHold$107.00ViewTweet This Rating  Share This Rating on StockTwits
12/18/2014Goldman SachsReiterated RatingHOLD$111.00ViewTweet This Rating  Share This Rating on StockTwits
12/18/2014Credit SuisseBoost Price TargetNeutral$111.00 -> $121.00ViewTweet This Rating  Share This Rating on StockTwits
12/17/2014Canaccord GenuityBoost Price TargetBuy$117.00 -> $147.00ViewTweet This Rating  Share This Rating on StockTwits
11/6/2014TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
11/7/2014Roth CapitalDowngradeBuy -> Neutral$155.00 -> $95.00ViewTweet This Rating  Share This Rating on StockTwits
11/7/2014Stifel NicolausDowngradeBuy -> Hold$185.00ViewTweet This Rating  Share This Rating on StockTwits
11/7/2014William BlairDowngradeOutperform -> Market Perform$184.00 -> $89.00ViewTweet This Rating  Share This Rating on StockTwits
8/20/2014JMP SecuritiesReiterated RatingMarket Outperform$173.00 -> $190.00ViewTweet This Rating  Share This Rating on StockTwits
8/8/2014Keefe, Bruyette & WoodsReiterated RatingOutperform$160.00 -> $147.00ViewTweet This Rating  Share This Rating on StockTwits
7/10/2014Brean CapitalBoost Price TargetBuy$125.00 -> $150.00ViewTweet This Rating  Share This Rating on StockTwits
6/10/2014Wells Fargo & Co.Initiated CoverageMarket Perform$126.00 -> $130.00ViewTweet This Rating  Share This Rating on StockTwits
3/18/2014National Alliance SecuritiesInitiated CoverageBuy$134.62ViewTweet This Rating  Share This Rating on StockTwits
1/7/2014Bank of AmericaDowngradeNeutral -> Underperform$86.00ViewTweet This Rating  Share This Rating on StockTwits
11/19/2013Janney Montgomery ScottReiterated RatingBuy$95.00ViewTweet This Rating  Share This Rating on StockTwits
11/11/2013SusquehannaBoost Price Target$75.00 -> $81.00ViewTweet This Rating  Share This Rating on StockTwits
6/12/2013Buckingham ResearchUpgradeNeutral -> Buy$53.00 -> $90.00ViewTweet This Rating  Share This Rating on StockTwits
5/28/2013RBC CapitalReiterated RatingBuy$60.00ViewTweet This Rating  Share This Rating on StockTwits
5/13/2013WallachBeth CapitalBoost Price TargetHold$45.00 -> $48.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 3/6/2013 forward)